Mancuso P - Search Results

1

Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies.

Hu-Lowe DD, Chen E, Zhang L, Watson KD, Mancuso P, Lappin P, Wickman G, Chen JH, Wang J, Jiang X, Amundson K, Simon R, Erbersdobler A, Bergqvist S, Feng Z, Swanson TA, Simmons BH, Lippincott J, Casperson GF, Levin WJ, Stampino CG, Shalinsky DR, Ferrara KW, Fiedler W, Bertolini F. Hu-Lowe DD, et al. Among authors: mancuso p. Cancer Res. 2011 Feb 15;71(4):1362-73. doi: 10.1158/0008-5472.CAN-10-1451. Epub 2011 Jan 6. Cancer Res. 2011. PMID: 21212415 Free PMC article.

2

Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma.

Bertolini F, Fusetti L, Mancuso P, Gobbi A, Corsini C, Ferrucci PF, Martinelli G, Pruneri G. Bertolini F, et al. Among authors: mancuso p. Blood. 2000 Jul 1;96(1):282-7. Blood. 2000. PMID: 10891463 Free article.

3

The thin red line: angiogenesis in normal and malignant hematopoiesis.

Bertolini F, Mancuso P, Gobbi A, Pruneri G. Bertolini F, et al. Among authors: mancuso p. Exp Hematol. 2000 Sep;28(9):993-1000. doi: 10.1016/s0301-472x(00)00508-7. Exp Hematol. 2000. PMID: 11008011 Free article. Review.

4

Resting and activated endothelial cells are increased in the peripheral blood of cancer patients.

Mancuso P, Burlini A, Pruneri G, Goldhirsch A, Martinelli G, Bertolini F. Mancuso P, et al. Blood. 2001 Jun 1;97(11):3658-61. doi: 10.1182/blood.v97.11.3658. Blood. 2001. PMID: 11369666 Free article.

5

Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma.

Monestiroli S, Mancuso P, Burlini A, Pruneri G, Dell'Agnola C, Gobbi A, Martinelli G, Bertolini F. Monestiroli S, et al. Among authors: mancuso p. Cancer Res. 2001 Jun 1;61(11):4341-4. Cancer Res. 2001. PMID: 11389057

6

Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers.

Bertolini F, Mingrone W, Alietti A, Ferrucci PF, Cocorocchio E, Peccatori F, Cinieri S, Mancuso P, Corsini C, Burlini A, Zucca E, Martinelli G. Bertolini F, et al. Among authors: mancuso p. Ann Oncol. 2001 Jul;12(7):987-90. doi: 10.1023/a:1011141009812. Ann Oncol. 2001. PMID: 11521807 Free article.

7

CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma.

Bertolini F, Dell'Agnola C, Mancuso P, Rabascio C, Burlini A, Monestiroli S, Gobbi A, Pruneri G, Martinelli G. Bertolini F, et al. Among authors: mancuso p. Cancer Res. 2002 Jun 1;62(11):3106-12. Cancer Res. 2002. PMID: 12036921

8

Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitors.

Capillo M, Mancuso P, Gobbi A, Monestiroli S, Pruneri G, Dell'Agnola C, Martinelli G, Shultz L, Bertolini F. Capillo M, et al. Among authors: mancuso p. Clin Cancer Res. 2003 Jan;9(1):377-82. Clin Cancer Res. 2003. PMID: 12538491

9

Circulating endothelial cells as a novel marker of angiogenesis.

Mancuso P, Calleri A, Cassi C, Gobbi A, Capillo M, Pruneri G, Martinelli G, Bertolini F. Mancuso P, et al. Adv Exp Med Biol. 2003;522:83-97. doi: 10.1007/978-1-4615-0169-5_9. Adv Exp Med Biol. 2003. PMID: 12674213

10

Stroma cells: a novel target of herceptin activity.

Corsini C, Mancuso P, Paul S, Burlini A, Martinelli G, Pruneri G, Bertolini F. Corsini C, et al. Among authors: mancuso p. Clin Cancer Res. 2003 May;9(5):1820-5. Clin Cancer Res. 2003. PMID: 12738740

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

353 results

Search Page

Filters